Nasdaq or NYSE related Health Care sector Top Companies List by Market Cap as of August 2026
Nasdaq or NYSE listed Health Care sector Top Companies List by Market Cap as of August 2026. Nasdaq and NYSE related Health Care sector Largest Companies List by Market Cap as of August 2026
-
World Rank (Aug-2026)4,693Market Cap (Aug-2026)3.373 Billion USDWorld Rank (Jan-05-2024)15,314Market Cap (Jan-05-2024)0.324 Billion USDWorld Rank (Jul-30-2023)13,144Market Cap (Jul-30-2023)0.469 Billion USDWorld Rank (Dec-25-2022)7,966Market Cap (Dec-25-2022)1.090 Billion USDWorld Rank (Jan-07-2022)9,983Market Cap (Jan-07-2022)0.90 Billion USDAnnual Revenue in USD524 Million USDAnnual Net Income in USD329 Million USDAnnual Results for Period EndingDec-2021 ending yearCompany ProfileBiotechnology company with headquarters is in Amsterdam, Netherlands.Company Website
-
AbCellera Biologics Inc.
World Rank (Aug-2026)4,707Market Cap (Aug-2026)3.353 Billion USDWorld Rank (Jan-05-2024)6,216Market Cap (Jan-05-2024)1.724 Billion USDWorld Rank (Jul-30-2023)5,362Market Cap (Jul-30-2023)2.220 Billion USDWorld Rank (Dec-25-2022)4,125Market Cap (Dec-25-2022)2.955 Billion USDWorld Rank (Jan-07-2022)4,491Market Cap (Jan-07-2022)3.33 Billion USDAnnual Revenue in USD288 Million USDAnnual Net Income in USD118 Million USDAnnual Results for Period EndingDec-2021 ending yearCompany ProfileABCELLERA BIOLOGICS INC. is Biotechnology sector company with headquarters is in Vancouver, Canada.Company WebsiteWikipedia -
Veracyte
World Rank (Aug-2026)4,732Market Cap (Aug-2026)3.316 Billion USDWorld Rank (Jan-05-2024)5,873Market Cap (Jan-05-2024)1.898 Billion USDWorld Rank (Jul-30-2023)5,673Market Cap (Jul-30-2023)2.035 Billion USDWorld Rank (Dec-25-2022)5,892Market Cap (Dec-25-2022)1.764 Billion USDWorld Rank (Jan-07-2022)5,608Market Cap (Jan-07-2022)2.39 Billion USDAnnual Revenue in USD517 Million USDAnnual Net Income in USD66 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileVeracyte is a Pioneering Genomic Diagnostics company. It's innovations in genomic technology and machine learning to enable more confident diagnostic, prognostic and treatment decisions in challenging diseases such as thyroid cancer, lung cancer, breast cancer and idiopathic pulmonary fibrosis. The headquarters is in USA.Company Website -
Celldex Therapeutics
World Rank (Aug-2026)4,755Market Cap (Aug-2026)3.294 Billion USDWorld Rank (Jan-05-2024)5,438Market Cap (Jan-05-2024)2.151 Billion USDWorld Rank (Jul-30-2023)6,490Market Cap (Jul-30-2023)1.640 Billion USDWorld Rank (Dec-25-2022)5,323Market Cap (Dec-25-2022)2.078 Billion USDWorld Rank (Jan-07-2022)6,911Market Cap (Jan-07-2022)1.71 Billion USDAnnual Revenue in USD2 Million USDAnnual Net Income in USD-259 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileCelldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Its pipeline includes immunotherapies and other targeted biologics derived from a broad set of complementary technologies which have the ability to engage the human immune system and/or directly inhibit tumors to treat specific types of cancer or other diseases. Headquarters is in USA.
Company Website -
Arcutis Biotherapeutics Inc.
World Rank (Aug-2026)4,757Market Cap (Aug-2026)3.292 Billion USDWorld Rank (Jan-05-2024)14,287Market Cap (Jan-05-2024)0.381 Billion USDWorld Rank (Jul-30-2023)10,942Market Cap (Jul-30-2023)0.667 Billion USDWorld Rank (Dec-25-2022)9,104Market Cap (Dec-25-2022)0.871 Billion USDWorld Rank (Jan-07-2022)9,768Market Cap (Jan-07-2022)0.94 Billion USDAnnual Revenue in USD372 Million USDAnnual Net Income in USD-16 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileArcutis Biotherapeutics is a Pioneering Medical Dermatology company dedicated to revolutionizing the treatment of serious skin diseases. It is focused on filling the innovation gap in medical dermatology drug development by applying deep clinical, product development and commercial expertise in dermatology to develop best in class therapies against biologically validated targets. It is having 29 employees as on 2019. The headquarters is in USA.Company Website -
NewAmsterdam Pharma Company N.V.
World Rank (Aug-2026)4,823Market Cap (Aug-2026)3.225 Billion USDWorld Rank (Jan-05-2024)8,641Market Cap (Jan-05-2024)0.989 Billion USDWorld Rank (Jul-30-2023)8,861Market Cap (Jul-30-2023)0.973 Billion USDWorld Rank (Dec-25-2022)8,503Market Cap (Dec-25-2022)0.973 Billion USDCompany Website -
Warby Parker Inc.
World Rank (Aug-2026)4,838Market Cap (Aug-2026)3.203 Billion USDWorld Rank (Jan-05-2024)6,249Market Cap (Jan-05-2024)1.706 Billion USDWorld Rank (Jul-30-2023)6,340Market Cap (Jul-30-2023)1.705 Billion USDWorld Rank (Dec-25-2022)6,386Market Cap (Dec-25-2022)1.564 Billion USDWorld Rank (Jan-07-2022)3,565Market Cap (Jan-07-2022)4.49 Billion USDAnnual Revenue in USD872 Million USDAnnual Net Income in USD2 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileWarby Parker Inc is a buying, designing glasses in house and online retail glasses company.
The headquarters is in USA.
As on Dec-2021, Warby Parker Inc has 161 retail stores.
For year ending Dec-2021 Warby Parker Inc Annual Revenue was 540 Million USD and Annual Net Income was -157 Million USD.
Company Website -
Pulse Biosciences
World Rank (Aug-2026)4,870Market Cap (Aug-2026)3.177 Billion USDWorld Rank (Jan-05-2024)11,984Market Cap (Jan-05-2024)0.555 Billion USDWorld Rank (Jul-30-2023)13,911Market Cap (Jul-30-2023)0.416 Billion USDWorld Rank (Dec-25-2022)21,978Market Cap (Dec-25-2022)0.094 Billion USDWorld Rank (Jan-07-2022)14,855Market Cap (Jan-07-2022)0.40 Billion USDAnnual Revenue in USD0 Million USDAnnual Net Income in USD-73 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfilePulse Biosciences is a Novel Bioelectric Medicine company committed to health innovation that has the potential to improve and extend the lives of patients. It have 112 issued patents globally owned and licensed. The company annual revenue is 343.5 million USD and 82 employees as on 2020. The headquarters is in USA.Company Website -
Iovance Biotherapeutics
World Rank (Aug-2026)4,887Market Cap (Aug-2026)3.162 Billion USDWorld Rank (Jan-05-2024)5,548Market Cap (Jan-05-2024)2.075 Billion USDWorld Rank (Jul-30-2023)6,175Market Cap (Jul-30-2023)1.782 Billion USDWorld Rank (Dec-25-2022)8,549Market Cap (Dec-25-2022)0.966 Billion USDWorld Rank (Jan-07-2022)5,413Market Cap (Jan-07-2022)2.55 Billion USDAnnual Revenue in USD264 Million USDAnnual Net Income in USD-391 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileIovance Biotherapeutics is a development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes company. The headquarters is in USA.Company Website -
Immunome Inc.
World Rank (Aug-2026)4,957Market Cap (Aug-2026)3.089 Billion USDWorld Rank (Jan-05-2024)12,539Market Cap (Jan-05-2024)0.505 Billion USDWorld Rank (Jul-30-2023)22,195Market Cap (Jul-30-2023)0.091 Billion USDWorld Rank (Dec-25-2022)26,459Market Cap (Dec-25-2022)0.038 Billion USDWorld Rank (Jan-07-2022)20,901Market Cap (Jan-07-2022)0.14 Billion USDAnnual Revenue in USD7 Million USDAnnual Net Income in USD-212 Million USDAnnual Results for Period EndingFor year ending December-2025Company Website